Carlos Franco-Muñoz

National Institute of Health — AM

Medicine · Health Sciences

13h-index555citations36works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(25), SARS-CoV-2 detection and testing(17), COVID-19 Clinical Research Studies(14), vaccines and immunoinformatics approaches(4), Plant Virus Research Studies(3)

Publications36 total

Molecular differentiation by PCR of the <i>Entamoeba dispar/histolytica/moshkovskii</i> complex in the population of Coyaima, Tolima, Colombia
2025Open Access
From Bioinformatics Analysis to Recombinant Expression: Advancing Public Health with Taenia solium Proteins
International Journal of Molecular Sciences·2025Open Access
Genomic surveillance of SARS-CoV-2 in the Andean Community (2020–2024): integrating regional sequencing efforts from Colombia, Ecuador, Peru, and Bolivia through “ORAS-CONHU” program
Frontiers in Public Health·2025· 1 citedOpen Access
Baseline Assessment of Taeniasis and Cysticercosis Infections in a High-Priority Region for Taenia solium Control in Colombia
Pathogens·2025· 1 citedOpen Access
The spatiotemporal ecology of Oropouche virus across Latin America: a multidisciplinary, laboratory-based, modelling study
The Lancet Infectious Diseases·2025· 18 citedOpen Access
Monkeypox virus infection in pregnancy: description of two cases reported to the Colombian National Institute of Health
Apmis·2024· 3 citedOpen Access
The Spatio-Temporal Ecology of Oropouche Virus: A Laboratory-Based Modelling Study Across Latin America
SSRN Electronic Journal·2024· 2 citedOpen Access
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia
Vaccines·2022· 4 citedOpen Access
Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia
International Journal of Infectious Diseases·2022· 4 citedOpen Access
Monkeypox virus genome sequence from an imported human case in Colombia
Biomédica·2022· 9 citedOpen Access
Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021
2022· 1 citedOpen Access
Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
The Lancet Regional Health - Americas·2022· 30 citedOpen Access
Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia
Vaccines·2022· 22 citedOpen Access
Low neutralizing antibody titers against the Mu variant of SARS-CoV-2 in BNT162b2 vaccinated individuals
2021Open Access
Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage
Virus Research·2021· 6 citedOpen Access
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
Infection Genetics and Evolution·2021· 140 citedOpen Access
Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K
Frontiers in Medicine·2021· 7 citedOpen Access
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
2021· 21 citedOpen Access
Novel highly divergent SARS-CoV-2 lineage with the Spike substitutions L249S and E484K
2021· 6 citedOpen Access
Seroprevalence of Anti-Sars-Cov-2 Antibodies in Colombia, 2020: A Population-Based Study
SSRN Electronic Journal·2021· 18 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Marcela Mercado(26), Katherine Laiton‐Donato(22), Diego A. Álvarez-Díaz(19), Martha Lucía Ospina Martínez(14), Héctor Alejandro Ruiz-Moreno(13), José A. Usme-Ciro(11), María T. Herrera-Sepúlveda(10), Diana Marcela Walteros Acero(10), Magdalena Wiesner(8), Nicolás D. Franco‐Sierra(7), Jhonnatan Reales-González(6), Sheryll Corchuelo(5), F. Alvarado(5), Zulma M. Cucunubá(5), Ana Luisa Muñoz(5), Marisol Galindo(5), Adriana Arévalo(5), Diego Andrés Prada(4), Julián Naizaque(4), Gerardo Santamaría(4)